Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 1, 2000, Pages 45-51

  Vakil, N ^a   Hahn, B ^b   McSorley, D ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; RANITIDINE BISMUTH CITRATE; UREASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENUM ULCER; EPIGASTRIC PAIN; ERADICATION THERAPY; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; HEARTBURN; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT PEPTIC ULCER; SYMPTOM;

ADULT; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; SMOKING; UREASE;

EID: 0033984043     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00677.x     Document Type: Article

References (23)

1. 1 Malliwah JA, Tabaqchali M, Watson J, Venables CW. Audit of the outcome of peptic ulcer disease diagnosed 10-20 years previously. Gut 1996; 38: 812-15.
2. 2 Penston JG, Dixon JS, Boyd EJS, Wormsley KG. A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine. Aliment Pharmacol Ther 1993; 7: 259-65.
3. 3 Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-12.
4. 4 Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven year follow-up. Lancet 1994; 343: 258-60.
5. 5 Fennerty MB. 'Cure' of Helicobacter pylori and 'cure' of peptic ulcer: do they mean the same thing? Am J Gastroenterol 1995; 90: 1203-4.
6. 6 Vakil N, Fennerty MB. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. Am J Gastroenterol 1996; 91: 239-45.
7. 7 Sonnenberg A, Schwartz SJ, Cutler A, Vakil N, Bloom BS. Cost savings in duodenal ulcer treatment through Helicobacter pylori eradication compared to conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group. Arch Intern Med 1998; 158: 852-60.
8. 8 Phull PS, Ryder SD, Halliday D, Price AB, Levi AJ, Jacyna MR. The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease - a community based study. Postgrad Mcd J 1995; 71: 413-18.
9. 9 Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer disease may provoke reflux oesophagitis. Gastroenterology 1997; 112: 1442-7.
10. 10 Veldhuyzen Van Zenten SJO, Tytgat KMAJ, Pollak PT, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis. J Clin Epidemiol 1993; 46: 273-9.
11. 11 Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux oesophagitis with low dose lansoprazole. Ann Intern Med 1996; 124: 859-67.
12. 12 Hallerback B, Unge P, Carling L, et al. Omeprazole or ranitidine in long-term treatment of reflux oesophagitis. Gastroenterology 1994; 107: 1305-11.
13. 13 Johannessen T, Peterson H, Kleveland PM, et al. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 689-97.
14. 14 Nyren O, Adami HO, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339-43.
15. 15 Phull PS, Halliday D, Price AB, Jacyna MR. Absence of dyspeptic symptoms as a test for Helicobacter pylori eradication. Br Med J 1996; 312: 349-50.
16. 16 McColl KEL, El-Nujumi A, Murray LS, et al. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer. Gut 1998; 42: 618-22.
17. 17 Goldman MS, Rasch JR, Wiltsie DS, Finkel M. The incidence of esophagitis in peptic ulcer disease. Am J Dig Dis 1967; 12: 994-9.
18. 18 Boyd EJS. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol 1996; 91: 1539-43.
19. 19 Reilly TG, Ayres RC, Poxon V, Walt RP. Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer. Aliment Pharmacol Ther 1995; 9: 483-90.
20. 20 Lahenz J. Borsch G, Blum A, Bayerdorffer E, Meining A, Stolte M. Reflux esophagitis and Helicobacter pylori. Gastroenterology 1997; 113: 2020-1.
21. 21 Galmiche JP, Bruley des Varennes S. Symptoms and disease severity in gastro-esophageal reflux disease. Scand J Gastroenterol 1994; 29(Suppl. 201): 62-8.
22. 22 Johnsson F, Joelsson B, Gudmondsson K, Grieff L. Symptoms and endoscopic findings in the diagnosis of gastro-esophageal reflux disease. Scand J Gastroenterol 1987; 22: 714-18.
23. 23 Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-esophageal reflux disease. Lancet 1990; 335: 205-8.